{"product_id":"university-of-miami-thinking-through-alzheimers-exploring-cognition-psychopharmacology-and-geriatric-psychiatry-2026","title":"University of Miami Thinking Through Alzheimer’s Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026","description":"\u003cdiv class=\"group-header field-group-div clearfix\"\u003e\r\n\u003cdiv class=\"group-header-inner field-group-div\"\u003e\r\n\u003cdiv class=\"group-course-header-right field-group-div\"\u003e\r\n\u003cdiv class=\"field field-name-title field-type-ds field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003ch3 class=\"product_title entry-title\"\u003eUniversity of Miami Thinking Through Alzheimer’s Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026\u003c\/h3\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe University of Miami Thinking Through Alzheimer’s Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026 course provides a comprehensive clinical update on dementia care and geriatric mental health. The program covers the spectrum from normal cognitive aging to early Alzheimer’s diagnosis, highlighting new breakthroughs in neuropsychological assessments, emerging biomarkers, and the latest pharmacological and non-pharmacological management strategies.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"474\"\u003eCourse Date:\u003c\/b\u003e February 23-27, 2026 | Monday-Friday | 9:00am to 12:15pm\u003c\/p\u003e\r\n\r\n\u003cul\u003e\r\n \t\u003cli\u003eAnxiety, depression and other mental health condition in later life can reduce longevity, increase the risk of medical and cognitive disorders and lead to poorer outcomes. Most concerning is the fact that the prevalence of cognitive disorders is increasing rapidly as people live longer. Reducing the risk of cognitive disorders such as Alzheimer’s Disease and Related Dementias (ADRD) is as essential to the clinician as reducing hypertension and diabetes in reducing cardiovascular disease.\u003c\/li\u003e\r\n \t\u003cli\u003eThis seminar is designed to educate the practitioners and equip them with essential knowledge and state-of-the-art scientific methods to diagnose Alzheimer’s Disease and Related Dementias (ADRD) at its earliest stages and assist patients and their loved ones. Understanding normal cognitive neurology and stradegies to reduce the risk of developing Alzheimer’s disease will also be discussed. Drawing on the presenters’ vast scientific and clinical expertise, the participants will be able to differentiate different cognitive syndromes and the etiological underpinnings of various clinical presentations. In addition, the participant will be familiarized with state-of-the-art neuropsychological and novel neuroimaging and plasma-based biomarkers methods to detect the earliest stages of Alzheimer’s Disease.\u003c\/li\u003e\r\n \t\u003cli\u003eThis presentation will also provide a comprehensive review of essential geriatric psychopharmacology in the treatment of the most common psychiatric and mental health conditions as well as the latest in emerging pharmacological agents in the treatment and management of Alzheimer’s Disease and its comorbid psychiatric and behavioral manifestations.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\nUpon completion of this activity, participants will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDescribe the promotion of brain health and longevity through evidence-based prevention.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate between normal cognitive neurology, mild cognitive impairment (MCI), and clinical dementia.\u003c\/li\u003e\r\n \t\u003cli\u003eDemonstrate how to identify the underlying brain disorders causing clinical cognitive impairment in older adults.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology\u003c\/li\u003e\r\n \t\u003cli\u003eDescribe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD).\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize geriatric psychopharmacology and how to optimally treat the more challenging geriatric mental health conditions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\nBest for psychiatrists and neurologists who want updates on Alzheimer’s biomarkers, cognitive assessments, and geriatric psychopharmacology.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003col start=\"1\" data-path-to-node=\"8\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,0,0\"\u003e01 Normal Cognitive Aging with Philip Harvey, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,1,0\"\u003e02 Delaying or Preventing Alzheimer’s Evidence-Based Risk Reduction With Kirsten CrenshaW, PsyD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,2,0\"\u003e03 Clinical Overview of Common Neurodegenerative Disorders in Older Adults With Alexandra Ortega, PsyD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,3,0\"\u003e04 New Breakthroughs in cognitive Neuropsychological Assessment With David Loewenstein, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,4,0\"\u003e05 Guiding Practitioners in Identifying Individuals Who Are Most at Risk for Amnestic MCI with Rosie Curiel-Cid, PsyD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,5,0\"\u003e06 Emerging Biomarkers in Diagnosing Early Alzheimer’s Disease with Rosie Curiel-Cid, PsyD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,6,0\"\u003e07 Treating the Family Constellation in Geriatric Psychiatry and Dementia with Elizabeth Crocco, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,7,0\"\u003e08 The Most Common Treatment Challenges in Geriatric Psychopharmacology with Elizabeth Crocco, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,8,0\"\u003e09 Pharmacological and Non-Pharmacological Management of Alzheimer’s and Related Dementias with Elizabeth Crocco, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,9,0\"\u003e10 The New Emerging Pharmacological Agents for Alzheimer’s Disease with Elizabeth Crocco, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954684006498,"sku":"MED-AMB08129","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Thinking-Through-Alzheimers-Exploring-Cognition-Psychopharmacology-and-Geriatric-Psychiatry-2026.jpg?v=1779382392","url":"https:\/\/meducourse.com\/products\/university-of-miami-thinking-through-alzheimers-exploring-cognition-psychopharmacology-and-geriatric-psychiatry-2026","provider":"Meducourse","version":"1.0","type":"link"}